Wisconsin Alumni Research Foundation has set up a pre-clinical drug discovery operation called Warf Therapeutics to help support biomedical projects.
University of Wisconsin-Madison’s independent commercialisation arm, Wisconsin Alumni Research Foundation (Warf), has formed a new pre-clinical drug discovery unit called Warf Therapeutics to help commercialise biomedical targets such as proteins and genes.
Warf Therapeutics’ remit covers the de-risking of specific disease targets so they are validated in terms of accuracy and reliability, in recognition of an increasingly complex patenting and approval process for medications.
Each project will undergo evaluations throughout the discovery and development process to determine its…
